Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
All the news from Servier
Patient Voices: “An accidental scan saved my life”
In the fight against Colorectal Cancer, Servier Supports Blue March
Servier x L’ADN: The new geopolitics of health
Neurology: a first clinical project in epileptic and developmental encephalopathy
The 2024/2025 Annual Report is available
How can we produce more medicines in a responsible and sustainable way?
Oncology — A strategic priority for Servier
Café Joyeux, happy employees!